Cagrilintide

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

1. 1

   1–2 Weeks

   Appetite-related effects are typically felt early, especially in combination with a GLP-1 compound.

2. 2

   3–4 Weeks

   A stronger, more consistent sense of fullness after smaller meals is commonly reported.

3. 3

   5–7 Weeks

   Early, gradual weight changes may begin to be noticed.

4. 4

   8–10 Weeks

   Continued appetite suppression is generally described as steady through this period.

5. 5

   11–15 Weeks

   Weight and appetite trends typically continue at a consistent pace.

6. 6

   16–20 Weeks

   Visible changes in body composition are commonly reported by this stage.

7. 7

   21–24 Weeks

   Many users are approaching or maintaining a stable dose and eating pattern.

⚠️ Research context only. This is not medical advice and results are not guaranteed.